Aravive, Inc. Profile Avatar - Palmy Investing

Aravive, Inc.

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets…

Biotechnology
US, Houston [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ARAV's Analysis
CIK: 1513818 CUSIP: 03890D108 ISIN: US03890D1081 LEI: - UEI: -
Secondary Listings
ARAV has no secondary listings inside our databases.